stage d2

Prostate cancer that has spread to distant lymph nodes or other organs.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2011
02419832011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Although multiple studies have addressed the prognostic importance of tumor differentiation in patients with clinically localized… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2003
2003
NY-ESO-1 mRNA expression was investigated in advanced prostate cancer by conventional and quantitative real-time reverse… (More)
Is this relevant?
2002
2002
Pepsinogen C is an aspartyl protease mainly involved in the digestion of proteins in the stomach, and an androgen-inducible… (More)
Is this relevant?
2001
2001
Pretreatment serum level of testosterone (T) is a potential prognostic factor for prostate cancer. However, T levels in Japanese… (More)
Is this relevant?
2001
2001
BACKGROUND Nested reverse-transcriptase polymerase chain reaction (nested rt-PCR) for the detection of mRNA of prostate specific… (More)
Is this relevant?
1994
1994
We studied 43 patients with newly diagnosed, untreated, stage D2 prostatic carcinoma, and correlated the initial performance… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
One hundred and one cases of clinical prostatic carcinoma (PCa), primary site, were analysed to define the interrelationship… (More)
Is this relevant?
1991
1991
This study was designed to compare the prognostic potential of tumor grade and ploidy status in patients with stage D2 prostate… (More)
Is this relevant?
1991
1991
The clinical significance of serum prostate specific antigen (PSA) values in hormonally treated prostate cancer patients and the… (More)
Is this relevant?
1991
1991
Flow cytometric DNA analysis was performed on 34 samples of prostatic carcinoma patients with stage D2 disease to study the… (More)
Is this relevant?